Deaths from injection-related infections like endocarditis have increased among young people, likely due to the growth of injection drug use and stronger, shorter-acting fentanyl. While medications ...

There are considerable gaps in provision of effective treatments for opioid use disorders (OUD) at U.S. substance use disorder (SUD) treatment facilities, according to a study published online July 11 ...

Braeburn Inc. today announced the presentation of three posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, FL, adding to the growing body of clinical and ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Los Angeles County jails pared back ...

Compared to patients adherent to monthly injectable buprenorphine, patients on other MOUD (adherent and non-adherent) were 3.5 to 8.1x more ...

The FDA approved Sublocade, Indivior’s once-monthly buprenophine injection, to treat opioid use disorder in adults with moderate-to-severe addiction. Here are four things to know. 1. Buprenophine for ...

Please provide your email address to receive an email when new articles are posted on . New data show that rapid initiation with once-monthly Sublocade significantly improved treatment retention vs.

Deaths from injection-related infections like endocarditis have increased among young people, likely due to the growth of injection drug use and stronger, shorter-acting fentanyl. While medications ...

The Food & Drug Administration (FDA) announced its approval of an injectable form of buprenorphine (brand name: Sublocade), a medication used to treat opiate addiction. Sublocade releases a steady ...

EXCLUSIVE — Washington, D.C. mayoral candidate Janeese Lewis George has floated the policy of opening safe injection sites in ...

Recent studies continue to support a decades-old drug as an alternative means of reducing alcohol consumption. The prescription opioid antagonist, called naltrexone, was first approved by the FDA to ...